JW Lifescience Revenue

In the year 2025, JW Lifescience had annual revenue of 257.83B KRW with 15.89% growth. JW Lifescience had revenue of 64.33B in the quarter ending December 31, 2025, with 17.40% growth.

Revenue

257.83B

Revenue Growth

+15.89%

P/S Ratio

0.79

Revenue / Employee

868.11M

Employees

297

Market Cap

202.85B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	257.83B	35.35B	15.89%
Dec 31, 2024	222.48B	15.62B	7.55%
Dec 31, 2023	206.86B	17.93B	9.49%
Dec 31, 2022	188.93B	19.11B	11.26%
Dec 31, 2021	169.82B	-13.70B	-7.47%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
REYON Pharmaceutical	145.93B
Jeil Pharmaceutical Co.,Ltd	567.24B
Samil Pharmaceutical Co.,Ltd	210.25B
SAMSUNG PHARM. Co., LTD.	44.29B
Whan In Pharm	255.21B
Ilyang Pharmaceutical Co.,Ltd	272.42B
AptaBio Therapeutics	3.70B
Suheung	722.31B

Revenue Rankings